News
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.” ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people getting the shot each year. “There may even be a ripple effect: public trust in ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U ...
The FDA announced it will limit full approval of future COVID-19 booster vaccines to individuals older than 65 and those at high risk for severe disease, marking a shift from the agency’s previous one ...
FDA outlines new COVID-19 vaccine regulations, requiring randomized trials when approving shots for healthy Americans. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results